Skip to content
10-K

Annual Report

EXOZYMES INC. EXOZ

0001493152-26-013563

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 29, 2026 8.48M sh
Shares Diluted FY 2025 · Dec 31, 2025 8.38M sh
Shares Diluted FY 2025 · Dec 31, 2024 6.56M sh
Capex FY 2025 · Dec 31, 2025 $169.92K
Capex FY 2025 · Dec 31, 2024 $396.45K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$6.5M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$8.51M
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.04M
Cash And Equivalents FY 2025 · Dec 31, 2024 $9.72M
Stockholders Equity FY 2025 · Dec 31, 2025 $3.4M
Stockholders Equity FY 2025 · Dec 31, 2024 $10.42M
Stockholders Equity FY 2025 · Dec 31, 2023 −$384.32K
Current Liabilities FY 2025 · Dec 31, 2025 $1.57M
Current Liabilities FY 2025 · Dec 31, 2024 $1.33M
Total Liabilities FY 2025 · Dec 31, 2025 $2.57M
Total Liabilities FY 2025 · Dec 31, 2024 $2.61M
Current Assets FY 2025 · Dec 31, 2025 $3.94M
Current Assets FY 2025 · Dec 31, 2024 $10.82M
Total Assets FY 2025 · Dec 31, 2025 $5.97M
Total Assets FY 2025 · Dec 31, 2024 $13.03M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.09
Eps Diluted FY 2025 · Dec 31, 2024 −$0.89
Eps Basic FY 2025 · Dec 31, 2025 −$1.09
Eps Basic FY 2025 · Dec 31, 2024 −$0.89
Sga Expense FY 2025 · Dec 31, 2025 $6.01M
Sga Expense FY 2025 · Dec 31, 2024 $4.06M
Rd Expense FY 2025 · Dec 31, 2025 $3.71M
Rd Expense FY 2025 · Dec 31, 2024 $1.87M
Net Income FY 2025 · Dec 31, 2025 −$9.16M
Net Income FY 2025 · Dec 31, 2024 −$5.86M
Operating Income FY 2025 · Dec 31, 2025 −$9.72M
Operating Income FY 2025 · Dec 31, 2024 −$5.93M